We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

MorphoSys Initiates Phase 2 Study of Anti-CD19 Antibody MOR208 in B-ALL

News   Apr 29, 2013

 
MorphoSys Initiates Phase 2 Study of Anti-CD19 Antibody MOR208 in B-ALL
 
 
 

RELATED ARTICLES

Cargo Trafficked Across Bacteria on "Treadmills"

News

Bacteria have more in common with human cells than first thought; cargo is transited along treadmill-like structures by viruses in a process similar to what is found in our own cells. Understanding the process is fundamental to developing tailor-made phages for resistant infections.

READ MORE

Fibroblasts Help Pancreatic Cancer Cells Evade Detection

News

A new study highlights the role of cancer-associated fibroblasts (CAFs) in helping cancer cells proliferate, survive and evade detection by the immune system.

READ MORE

Checkmate for Hepatitis B in the Liver

News

Chronic infection with the hepatitis B virus has been conquered in a mouse model, thanks to the work of German researchers and T cell therapy.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE